Emory Brain Health Center
Emory Brain Health Center
Atlanta, Georgia, United States8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Seizures, Focal, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, visual epilepsy | Recruiting | Phase 3 | 2026-10-08 | NCT07563881 | |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Phase 3 | 2026-10-08 | NCT05667142 | |
| The PREVENT Resilience Study | Psychological Trauma, Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Not applicable | 2026-09-08 | NCT07568145 | |
| A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cervical dystonia, dystonic disorder, inherited torticollis | Recruiting | Phase 2 | 2026-09-08 | NCT06937931 | |
| Cortical Electrophysiology of Response Inhibition in Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 4 | 2026-09-03 | NCT06234995 | |
| MDMA Plus Exposure Therapy for PTSD | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Enrolling by invitation | Phase 2 | 2026-07-08 | NCT05746572 | |
| MDMA-Assisted Massed Exposure Therapy for PTSD | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-05-26 | NCT07288151 | |
| A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG) | New Onset Generalized Myasthenia Gravis (gMG) | Recruiting | Phase 4 | 2026-03-10 | NCT06909214 |